Terminated PHASE1/PHASE2 INTERVENTIONAL 1-arm NCT01052090

Safety and Efficacy Study in Hepatitis C Patients With PHN121 (ENCHAMP)

Safety and Efficacy Study in Non-Responder Hepatitis C Genotype 1 Patients With PHN121

Sponsor: PhytoHealth Corporation

Interventions PHN121

Updated 6 times since 2017 Last updated: Nov 24, 2013 Started: Sep 30, 2009 Primary completion: Nov 30, 2013 Completion: Dec 31, 2013

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

This trial was terminated. No reason was provided.

Other terminated trials from PhytoHealth Corporation

More terminations from PhytoHealth Corporation

Other Hepatitis C Virus Infection trials with similar outcome

Browse all Hepatitis C Virus Infection trials

Listed as NCT01052090, this PHASE1/PHASE2 trial focuses on Hepatitis C Virus Infection and remains terminated or withdrawn. Sponsored by PhytoHealth Corporation, it has been updated 6 times since 2009, reflecting limited change activity. This study is part of the global effort to build evidence for infectious disease interventions.

Status Flow

Change History

6 versions recorded

Sep 2025 — Present [monthly]

Terminated PHASE1/PHASE2
Sep 2024 — Sep 2025 [monthly]

Terminated PHASE1/PHASE2
Jul 2024 — Sep 2024 [monthly]

Terminated PHASE1/PHASE2

Phase: PHASE1_PHASE2 → PHASE1/PHASE2
Jan 2021 — Jul 2024 [monthly]

Terminated PHASE1_PHASE2
Jun 2018 — Jan 2021 [monthly]

Terminated PHASE1_PHASE2

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Terminated PHASE1_PHASE2

First recorded

Sep 2009

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

PhytoHealth Corporation

Data source: PhytoHealth Corporation

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Kaohsiung City, Taiwan
• Taipei, Taiwan